Skip to main content
Clinical Trials/IRCT20190901044666N4
IRCT20190901044666N4RecruitingPhase 3

Evaluation of the efficacy of fractional CO2 laser in combination with 5-fluorouracil cream compared to PDL laser in the treatment of hypertrophic and keloidal scars: A randomized controlled clinical trial

Iran University of Medical Sciences0 sites24 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
24

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to no limit (—)
Sex
All

Inclusion Criteria

  • Patients over 18 years old
  • Patients with a confirmed diagnosis of erythematous hypertrophic scar in the number of at least 2
  • The size of the waste should be at least 5x5 cm square or have a length of at least 5 cm
  • The patient is not pregnant or breastfeeding
  • During the last two months, the patient has not received any treatment for the lesions, including laser treatment, topical or injectable corticosteroids
  • The patient has no underlying diseases that lead to scar healing process; such as diabetes or weakened immune system
  • The patient's cooperation in carrying out therapeutic interventions and referring for all therapeutic sessions

Exclusion Criteria

  • Not provided

Investigators

Similar Trials